Department of Epidemiology and Evaluation, IMIM (Hospital del Mar Medical Research Institute), Passeig Marítim, 25-29, 08003, Barcelona, Spain.
European Higher Education Area (EHEA) Doctoral Programme in Methodology of Biomedical Research and Public Health in Department of Pediatrics, Obstetrics and Gynecology, Preventive Medicine and Public Health, Universitat Autónoma de Barcelona (UAB), Bellaterra, Barcelona, Spain.
J Cancer Surviv. 2019 Jun;13(3):477-493. doi: 10.1007/s11764-019-00755-z. Epub 2019 Apr 9.
Long-term breast cancer survivors are women surviving at least 5 years after diagnosis. This systematic review aimed to summarize the main characteristics and patterns of healthcare service use (frequency of visits, health providers visited, and preventive care performed) among long-term breast cancer survivors.
We used standard Cochrane Collaboration methods and searched the MEDLINE and EMBASE databases up to January 2018. We included English language observational studies reporting health service use among long-term cancer survivors. The quality of the studies was appraised through the ROBINS-I assessment tool. Two independent reviewers performed both the study quality assessment and the data extraction.
A total of 23 observational studies were included that reported data on health services use by long-term breast cancer survivors. Despite heterogeneity among studies, about half of them reported that breast cancer survivors visited a medical provider at least once a year, as recommended by breast cancer survival guidelines. Although survivors visited medical providers with the recommended frequency, a substantial number used specialist care instead of primary care during follow-up. The results showed underuse of the recommended annual mammogram.
Long-term breast cancer survivors differ in their health services use with regard to the frequency of visits as well as the health providers seen. Our results indicate the need for active surveillance through primary care providers in coordination with specialized care.
This review could help to standardize the management of breast cancer survivors and decision-makers to adapt their guidelines and clinical protocols.
长期乳腺癌幸存者是指在诊断后至少存活 5 年的女性。本系统评价旨在总结长期乳腺癌幸存者医疗服务利用的主要特征和模式(就诊频率、就诊的医疗服务提供者和进行的预防保健)。
我们使用标准的 Cochrane 协作方法,检索了 MEDLINE 和 EMBASE 数据库,检索时间截至 2018 年 1 月。我们纳入了报告长期癌症幸存者医疗服务利用情况的英语观察性研究。通过 ROBINS-I 评估工具评估研究质量。两名独立的综述作者同时进行研究质量评估和数据提取。
共纳入 23 项观察性研究,这些研究报告了长期乳腺癌幸存者医疗服务利用的数据。尽管研究之间存在异质性,但其中约一半的研究报告称,乳腺癌幸存者按照乳腺癌生存指南的建议,至少每年就诊一次。尽管幸存者按照建议的频率就诊,但在随访期间,大量幸存者使用专科护理而不是初级保健。研究结果表明,推荐的每年进行一次乳房 X 线摄影检查的利用率较低。
长期乳腺癌幸存者在就诊频率以及就诊的医疗服务提供者方面存在差异。我们的研究结果表明,需要通过初级保健提供者与专科护理协调,进行积极监测。
本综述有助于标准化乳腺癌幸存者的管理,使决策者能够调整他们的指南和临床方案。